Related Experiment Video
Updated: Jun 2, 2026
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Fetuin-A, coronary artery calcification and outcome in maintenance hemodialysis patients
1Department of Internal Medicine, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon, South Korea. haehyuk@kangwon.ac.kr
Insights
Serum fetuin-A levels predict survival and cardiovascular events in dialysis patients. This association remains significant even after accounting for vascular calcification, highlighting fetuin-A
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Serum fetuin-A, a known calcification inhibitor, has been implicated in predicting mortality among dialysis patients.
- Understanding the role of fetuin-A in vascular calcification and patient outcomes is crucial for improving care.
Purpose of the Study:
- To investigate the relationship between serum fetuin-A levels, vascular calcification, and clinical outcomes in patients undergoing maintenance hemodialysis.
- To determine if fetuin-A predicts mortality and cardiovascular events independently of coronary artery calcification (CAC).
Main Methods:
- A cohort of 58 maintenance hemodialysis patients was studied.
- Coronary artery calcification (CAC) was assessed at baseline using multirow spiral computed tomography.
- Serum fetuin-A levels were measured repeatedly throughout the study period.
Main Results:
- Time-averaged fetuin-A showed an inverse correlation with age and baseline CAC score.
- The association between fetuin-A and CAC was not significant after adjusting for age.
- Low serum fetuin-A levels were significantly associated with increased all-cause mortality and cardiovascular events.
- This association persisted even after adjusting for confounding factors, including age and CAC score.
Conclusions:
- Serum fetuin-A is a significant predictor of survival and cardiovascular outcomes in dialysis patients.
- The predictive value of fetuin-A for mortality and cardiovascular events is independent of the extent of vascular calcification.
Background/Aims:
Previous studies have suggested that serum fetuin-A, a calcification inhibitor, predicts mortality in dialysis patients. This study investigated the relationships between fetuin-A, vascular calcification, and outcome in such patients.
Methods:
58 patients on maintenance hemodialysis underwent multirow spiral computed tomography to determine baseline coronary artery calcification (CAC) score. Serum fetuin-A was measured repeatedly over time.
Results:
Time-averaged fetuin-A inversely correlated with age and baseline CAC score. After partial correlation analysis controlling for age, the association between fetuin-A and CAC became insignificant. During the study, 27 of 58 patients died and 26 experienced at least one cardiovascular event. Low fetuin-A was associated with a significant increase in all-cause mortality and the occurrence of a cardiovascular event. The association of fetuin-A with mortality and cardiovascular event remained significant even when adjusting for confounding factors, including age and CAC score.
Conclusion:
Time-averaged fetuin-A was associated with survival and cardiovascular outcome, independent of vascular calcification.
